Commodore Capital LP Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$290.3B
Holdings
29
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACRSACLARIS THERAPEUTICS INC | 1,668,987 | $29.3B | 10.09% | |
| 2 | —SATSUMA PHARMACEUTICALS INC | 3,096,729 | $21.8B | 7.52% | |
| 3 | CELCCELCUITY INC | 870,967 | $20.9B | 7.20% | |
| 4 | CCCCC4 THERAPEUTICS INC | 481,094 | $18.2B | 6.27% | |
| 5 | CBAYUSDCYMABAY THERAPEUTICS INC | 3,529,465 | $15.4B | 5.30% | |
| 6 | —CONSTELLATION PHARMCETICLS I | 440,869 | $14.9B | 5.13% | |
| 7 | CYTKCYTOKINETICS INC | 704,317 | $13.9B | 4.80% | |
| 8 | KURAKURA ONCOLOGY INC | 621,493 | $13.0B | 4.46% | |
| 9 | COGTCOGENT BIOSCIENCES INC | 1,367,582 | $11.1B | 3.82% | |
| 10 | OPHTEURIVERIC BIO INC | 1,748,241 | $11.0B | 3.80% | |
| 11 | TCE2CELLDEX THERAPEUTICS INC NEW | 323,437 | $10.8B | 3.73% | |
| 12 | MGNXMACROGENICS INC | 393,850 | $10.6B | 3.64% | |
| 13 | VTGNUSDVISTAGEN THERAPEUTICS INC | 3,331,315 | $10.5B | 3.61% | |
| 14 | PTGXPROTAGONIST THERAPEUTICS INC | 210,600 | $9.5B | 3.26% | |
| 15 | EPIEURESSA PHARMA INC | 281,911 | $8.1B | 2.77% | |
| 16 | KRON1USDKRONOS BIO INC | 298,839 | $7.2B | 2.47% | |
| 17 | GNCAQGENOCEA BIOSCIENCES INC | 2,929,447 | $6.9B | 2.36% | |
| 18 | VRDNVIRIDIAN THERAPEUTICS INC | 366,414 | $6.7B | 2.31% | |
| 19 | MREOMEREO BIOPHARMA GROUP PLC | 2,059,729 | $6.5B | 2.25% | |
| 20 | DYNDYNE THERAPEUTICS INC | 305,125 | $6.4B | 2.21% | |
| 21 | XENEXENON PHARMACEUTICALS INC | 326,336 | $6.1B | 2.09% | |
| 22 | —MERSANA THERAPEUTICS INC | 429,228 | $5.8B | 2.01% | |
| 23 | KALVKALVISTA PHARMACEUTICALS INC | 226,671 | $5.4B | 1.87% | |
| 24 | PMVPPMV PHARMACEUTICALS INC | 125,000 | $4.3B | 1.47% | |
| 25 | IVAINVENTIVA SA | 262,658 | $3.6B | 1.23% | |
| 26 | MCRB1EURSERES THERAPEUTICS INC | 145,453 | $3.5B | 1.19% | |
| 27 | —CATABASIS PHARMACEUTICALS IN | 1,617,000 | $3.4B | 1.18% | |
| 28 | SPRYSILVERBACK THERAPEUTICS INC | 97,143 | $3.0B | 1.03% | |
| 29 | —BCLS ACQUISITION CORP | 250,000 | $2.6B | 0.91% |